Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the use of our report dated February 22, 2024, with respect to the financial statements of Edgewise Therapeutics, Inc., incorporated herein by reference.
/s/ KPMG LLP
Denver, Colorado
May 9, 2024
